A detailed history of Newfound Research LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Newfound Research LLC holds 2,198 shares of BSX stock, worth $224,899. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,198
Previous 2,551 13.84%
Holding current value
$224,899
Previous $95,000 10.53%
% of portfolio
0.21%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$36.71 - $109.66 $12,958 - $38,709
-353 Reduced 13.84%
2,198 $85,000
Q2 2022

Jul 15, 2022

BUY
$35.24 - $47.1 $32,385 - $43,284
919 Added 56.31%
2,551 $95,000
Q1 2022

May 04, 2022

BUY
$40.9 - $45.1 $2,167 - $2,390
53 Added 3.36%
1,632 $72,000
Q4 2021

Jan 19, 2022

BUY
$38.07 - $44.87 $10,393 - $12,249
273 Added 20.9%
1,579 $67,000
Q3 2021

Oct 14, 2021

BUY
$41.23 - $45.88 $53,846 - $59,919
1,306 New
1,306 $57,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.